FDA to Restructure Generic Drug Office to Stay on Top of Reviews

By Sam | February 1, 2021

The Center for Drug Evaluation and Research (CDER) is set to reorganize its Office of Generic Drugs (OGD) to help keep up with the high volume of generic drug applications.
Source: Drug GMP Report

Posted in Drug GMP Report